CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors — Stella

Recruiting

Back to Renal Cell Carcinoma (RCC) trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, Anhui

Key details

Phase

Early testing

Sponsor

Chongqing Precision Biotech Co., Ltd

Enrollment target

~90 participants

Started

September 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov